Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gupta, M.
Right arrow Articles by Kohli, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, M.
Right arrow Articles by Kohli, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Add-On Melatonin Improves Sleep Behavior in Children With Epilepsy: Randomized, Double-Blind, Placebo-Controlled Trial

Madhur Gupta, MD

Department of Pharmacology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India, madhurgupta{at}hotmail.com.

Satinder Aneja, MD

Department of Pediatrics, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India

Kamlesh Kohli, MD

Department of Pharmacology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India

This double-blind, randomized, placebo-controlled study in epileptic children, aged 3 to 12 years, evaluated the effect of add-on melatonin on the sleep behavior of these children on sodium valproate monotherapy using a parental questionnaire. Of the 31 patients, 16 randomly received add-on melatonin, whereas 15 received add-on placebo. The questionnaire showed good internal consistency in our patient population (Cronbach's {alpha} = .83). The percentage decrease in the median total sleep score was 24.4 (range 0.0—34.9) in the valproate + melatonin group compared with 14.0 (range —2.2—18.8) in the valproate + placebo group, the difference being statistically significant (P < .05). The median percentage decrease in the parasomnias score was 60 (range 0.0—70.8) in the valproate + melatonin group compared with 36.4 (range 0.0—63.2) in the valproate + placebo group, the difference being statistically significant (P < .05). There was no significant difference between the percentage decrease in the daytime drowsiness scores and sleep fragmentation scores. Parent-child interaction subscale scores were not significantly different between age groups. The age at onset of seizures and the type of seizures did not correlate significantly to the total sleep scores. Given that sleep problems are known to complicate epilepsy, add-on melatonin, which has a wide safety window, can be of promise in the pharmacotherapy of pediatric epilepsy. (J Child Neurol 2005;20:112—115).

Journal of Child Neurology, Vol. 20, No. 2, 112-115 (2005)
DOI: 10.1177/08830738050200020501


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?